Fig. 4From: The efficacy of clopidogrel in preventing recurrent cardiovascular events among Arab population carrying different CYP2C19 mutations: systematic review and meta-analysisForest plot showing the frequency of recurrent CVEs among carriers and non-carriers of CYP2C19*17 mutation, and results of odds ratiosBack to article page